Mustard NPR1, a mammalian IκB homologue inhibits NF-κB activation in human GBM cell lines

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 427-433

  Kesanakurti, Divya ^a   Sareddy, Gangadhara Reddy ^a   Babu, Phanithi Prakash ^a   Kirti, Pulugurtha Bharadwaja ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

I B; Mustard; NF B; NPR1; p50; p65; U373

Indexed keywords

ANKYRIN; CASPASE 3; CASPASE 8; CYCLIN D1; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN NPR1; UNCLASSIFIED DRUG;

ARTICLE; BRASSICA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANKYRIN REPEAT; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLOOXYGENASE 2; DOWN-REGULATION; EIF-2 KINASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; MOLECULAR SEQUENCE DATA; MUSTARD PLANT; NEOPLASMS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PLANT PROTEINS; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-MYC;

BRASSICA JUNCEA; MAMMALIA;

EID: 70449715125     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.046     Document Type: Article

References (29)

1. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappa B in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
2. Ghosh S., and Karin M. Missing pieces in the NF-kappa B puzzle. Cell 109 (2002) S81-S96
3. Nishikori M. Classical and alternative NF-κB activation pathways and their roles in lymphoid malignancies. J. Clin. Exp. Hematopathol. 45 (2005) 15-24
4. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
5. Voronin D.A., and Kiseleva E.V. Functional roles of proteins containing ankyrin repeats. Cell Tissue Biol. 2 (2008) 1-12
6. Mosavi L.K., Cammett T.J., Desrosiers D.C., and Peng Z.-Y. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13 (2004) 1435-1448
7. Cao H., Glazebrook J., Clarke J.D., Volko S., and Dong X. The Arabidopsis NPR1 gene that controls systemic acquired resistance encodes a novel protein containing ankyrin repeats. Cell 88 (1997) 57-63
8. Ryals J., Weymann K., Lawton K., Friedrich L., Ellis D., Steiner H.-.Y., Johnson J., Delaney T.P., Jesse T., Vos P., and Uknes S. The arabidopsis NIM1 protein shows homology to the mammalian transcription factor inhibitor I kappa B. Plant Cell 9 (1997) 425-439
9. Ravi R., and Bedi A. NF-κB in cancer-a friend or foe. Drug Resist. Updat. 7 (2004) 53-67
10. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
11. Nurnberger T., Brunner F., Kemmerling B., and Piater L. Innate immunity in plants and animals: striking similarities and obvious differences. Immunol. Rev. 198 (2004) 249-266
12. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26
13. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186
14. Yamamoto M., Yamazuki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto N., Yamamoto S., Muta T., Takeda K., and Akira S. Regulation of Toll/IL-1-receptor mediated gene expression by the inducible nuclear protein IkappaB-zeta. Nature 430 (2004) 218-222
15. Wyler E., Kaminska M., Coic Y.-M., Baleux F., Veron M., and Agou F. Inhibition of NF-κB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO. Protein Sci. 16 (2007) 2013-2022
16. Hatada E.N., Nieters A., Wulczyn F.G., Naumann M., Meyer R., Nucifora G., McKeithan W., and Scheidereit C. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bc1-3 act as specific inhibitors of NF-kappa B DNA binding. Proc. Natl. Acad. Sci. USA 89 (1992) 2489-2493
17. Naumann M., Nieters A., Hatada E.N., and Scheidereit C. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. Oncogene 8 (1993) 2275-2281
18. Inoue J., Kerr L.D., Kakizuka A., and Verma I.M. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell 68 (1992) 1109-1120
19. Basak S., Kim H., Kearns J.D., Tergaonkar V., O'dea E., Werner S.L., Benedict C.A., Ware C.F., Ghosh G., Verma I.M., and Hoffmann A. A fourth IκB protein within the NF-κB signaling module. Cell 128 (2007) 369-381
20. Meur G., Budatha M., Dutta Gupta A., Prakash S., and Kirti P.B. Differential induction of NPR1 during defense responses in Brassica juncea. Physiol. Mol. Plant Pathol. 68 (2006) 128-137
21. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
22. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
23. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., and Haegeman G. P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappa B p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273 (1998) 3285-3290
24. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481 (2001) 243-268
25. Koivunen J., Aaltonen V., and Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett. 235 (2006) 1-10
26. Mackay H.J., and Twelves C.J. Protein kinase C: a target for anticancer drugs?. Endocr. Relat. Cancer 10 (2003) 389-396
27. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
28. Denault J.B., and Salvesen G.S. Caspases: keys in the ignition of cell death. Chem. Rev. 102 (2002) 4489-4499
29. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290